Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes

Keyphrases

• Intracardiac 100%
• Refractory Hypertension 100%
• Intravascular Fluids 100%
• Fluid Retention 100%
• Resistant Hypertension 50%
• Treatment Failure 20%
• Hypertension Patients 20%
• Cardiac Magnetic Resonance 20%
• Antihypertensive Treatment 20%
• Blood Pressure 10%
• Posterior Wall Thickness 10%
• Consecutive Patients 10%
• Operative 10%
• Diastolic Dysfunction 10%
• Biochemical Tests 10%
• B-type Natriuretic Peptide 10%
• Mineralocorticoid Receptor Antagonists 10%
• Antihypertensive Medication 10%
• Exclusion Criteria 10%
• Left Ventricular Volume 10%
• Left Ventricular Mass 10%
• Diuretics 10%
• Kidney Disease Progression 10%
• Left Ventricular Hypertrophy 10%
• Enlargement 10%
• Blood Pressure Control 10%
• Extreme Phenotypes 10%
• Septal Wall Thickness 10%
• White-coat Hypertension 10%
• Thiazides 10%
• Volume Retention 10%
• Left Atrial Volume 10%
• Intravascular Volume 10%

Medicine and Dentistry

• Hypertension 100%
• Fluid Retention 100%
• Resistant Hypertension 50%
• Blood Pressure 20%
• Cardiac Magnetic Resonance Imaging 20%
• Antihypertensive Therapy 20%
• Brain Natriuretic Peptide 10%
• Antihypertensive Agent 10%
• Pressure Control 10%
• Chronic Kidney Disease 10%
• Left Ventricular Hypertrophy 10%
• Diastolic Dysfunction 10%
• White Coat Hypertension 10%
• Thiazide Diuretic Agent 10%
• Mineralocorticoid Antagonist 10%
• Diuretics 10%

Neuroscience

• Hypertension 100%
• Antihypertensive Agent 18%
• Cardiac Magnetic Resonance Imaging 12%
• Receptor Antagonist 6%
• Left Ventricular Hypertrophy 6%
• Mineralocorticoid Receptor 6%
• Brain Natriuretic Peptide 6%
• Thiazide 6%
• Diuretic 6%